Breast Cancer & Hormones

Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study
Graham A. Colditz, Meir J . Stampfer, Walter C. Willett, David J . Hunter, J oAnn E. Manson, Charles H. Hennekens, Bernard A. Rosner and Frank ...
Fri, 2 Sep, 2016 at 6:50 AM
Epidemiology of breast cancer. Findings from the nurses' health study
Colditz GA Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts. ...
Fri, 2 Sep, 2016 at 6:51 AM
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
Graham A. Colditz, M.B., B.S., Susan E. Hankinson, Sc.D., David J. Hunter, M.B., B.S., Walter C. Willett, M.D., JoAnn E. Manson, M.D., Meir J. S...
Fri, 2 Sep, 2016 at 6:53 AM
Œstrogen fractions during early reproductive life in the ætiology of breast cancer
Philip Cole, Brian MacMahon Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115. ...
Fri, 2 Sep, 2016 at 6:54 AM
The Effect of Testosterone Propionate Therapy on Clinical Course and Hormonal Excretion
Albert Segaoff, M.D., Douglas Gordon. M.D., Benjamin N. Howitt, PH.D., Joseph V. Schlosser, M.D., and Paul J. Murison, M.D. From ...
Fri, 9 Sep, 2016 at 8:09 AM
The Incidence of Invasive Breast Cancer Among Women Prescribed Testosterone for Low Libido
Susan R. Davis, MD, PhD,* Rory Wolfe, PhD,† Helen Farrugia, B Appl Sci,‡ Angeline Ferdinand, BA, MPH,* and Robin J. Bell, MD, PhD, MPH* ...
Fri, 9 Sep, 2016 at 8:11 AM
Tibolone is not converted by human aromatase to 7α-methyl-17α-ethynylestradiol (7α-MEE): Analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS
Marcel E. de Gooyer*, Hendrika M. Oppers-Tiemissen, Dirk Leysen, Herman A.M. Verheul, Helenius J. Kloosterboer N.V Organon, Resear...
Fri, 9 Sep, 2016 at 8:15 AM
Estrogen replacement therapy in breast cancer survivors: a matched-controlled series
David A. Decker, MD,1 Jane E. Pettinga, MD,2 Nancy VanderVelde,MD,1 Ray win R. Huang, PhD,4 Larry Kestin, MD,3 and John H, Burdakin, MD1 ...
Fri, 9 Sep, 2016 at 8:18 AM
Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women
B. de Lignières, F. de Vathaire*, S. Fournier, R. UrbinelW, F. Allaer†, M. G. Le* and F. Kuttenn Service d’Endocrinologie et Médec...
Fri, 9 Sep, 2016 at 8:20 AM
Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study
J. E. Dew, B. G. Wren and J. A. Eden School of Women’s and Children’s Health, University of New South Wales, Royal Hospital for Wo...
Fri, 9 Sep, 2016 at 8:21 AM